Why the study?
Does adjuvant chemotherapy with adriamycin and DTIC improve disease-free survival in adults with primary soft tissue sarcomas compared to surgery alone?
Population
257 adults with primary soft tissue sarcomas
Comparison
Adjuvant chemotherapy consisting of adriamycin… vs Surgical resection alone
Design
Cohort
Follow-up
5 years
Authors
Loading...
May support adjuvant chemotherapy after sarcoma resection; hypothesis-generating and requires randomized confirmation.
Does adjuvant chemotherapy with adriamycin and DTIC improve disease-free survival in adults with primary soft tissue sarcomas compared to surgery alone?
Adjuvant chemotherapy with adriamycin and DTIC improves 2-year and 5-year disease-free survival in adults with primary soft tissue sarcomas compared to surgery alone.
Gupta et al. (1982) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: